| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL3A1 COL4A3 COL9A2 LAMA2 LAMA5 LAMB1 SSPOP CRELD1 FBN2 MUC5AC TNXB | 1.35e-09 | 188 | 94 | 11 | GO:0005201 |
| GeneOntologyMolecularFunction | calcium ion binding | TRPM4 STAB2 PCDHA3 SVEP1 JAG2 CRELD1 FBN2 ARSA MEGF6 MEGF8 DLL3 UMOD EGFL7 NOTCH3 NOTCH4 CRB2 | 3.92e-07 | 749 | 94 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | structural molecule activity | COL3A1 COL4A3 COL9A2 MAP1A LAMA2 LAMA5 LAMB1 SSPOP CLDN9 KRT73 CRELD1 FBN2 MUC5AC TNXB KRT38 KRT37 | 3.78e-06 | 891 | 94 | 16 | GO:0005198 |
| GeneOntologyMolecularFunction | Notch binding | 7.44e-06 | 27 | 94 | 4 | GO:0005112 | |
| GeneOntologyMolecularFunction | integrin binding | 1.90e-05 | 175 | 94 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 4.13e-04 | 31 | 94 | 3 | GO:0099604 | |
| GeneOntologyCellularComponent | extracellular matrix | COL3A1 COL4A3 LAMB4 INHBE COL9A2 LAMA2 LAMA5 LAMB1 SSPOP SVEP1 CRELD1 FBN2 FCGBP IGFALS MEGF6 EGFL7 MUC5AC TNXB | 9.64e-10 | 656 | 96 | 18 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL3A1 COL4A3 LAMB4 INHBE COL9A2 LAMA2 LAMA5 LAMB1 SSPOP SVEP1 CRELD1 FBN2 FCGBP IGFALS MEGF6 EGFL7 MUC5AC TNXB | 1.01e-09 | 658 | 96 | 18 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL3A1 COL4A3 LAMB4 INHBE COL9A2 LAMA2 LAMA5 LAMB1 SSPOP CRELD1 FBN2 MEGF6 EGFL7 TNXB | 1.36e-07 | 530 | 96 | 14 | GO:0062023 |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 6.09e-05 | 17 | 96 | 3 | GO:0098637 | |
| GeneOntologyCellularComponent | laminin-10 complex | 6.24e-05 | 3 | 96 | 2 | GO:0043259 | |
| GeneOntologyCellularComponent | basement membrane | 2.49e-04 | 122 | 96 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | laminin complex | 9.17e-04 | 10 | 96 | 2 | GO:0043256 | |
| Domain | EGF | HGFAC STAB2 ADAM23 LAMA2 LAMA5 LAMB1 SVEP1 JAG2 CRELD1 CNTNAP5 FBN2 FCGBP MEGF6 MEGF8 DLL3 BRINP2 UMOD ADAM33 EGFL7 TNXB NOTCH3 NOTCH4 CRB2 PEAR1 | 3.82e-25 | 235 | 93 | 24 | SM00181 |
| Domain | EGF_1 | HGFAC LAMB4 STAB2 ADAM23 LAMA2 LAMA5 LAMB1 SSPOP SVEP1 JAG2 CRELD1 CNTNAP5 FBN2 MEGF6 MEGF8 DLL3 UMOD ADAM33 EGFL7 TNXB NOTCH3 NOTCH4 CRB2 PEAR1 | 2.79e-24 | 255 | 93 | 24 | PS00022 |
| Domain | EGF_2 | HGFAC LAMB4 STAB2 ADAM23 LAMA2 LAMA5 LAMB1 SSPOP SVEP1 JAG2 CRELD1 CNTNAP5 FBN2 MEGF6 MEGF8 DLL3 UMOD ADAM33 EGFL7 TNXB NOTCH3 NOTCH4 CRB2 PEAR1 | 7.07e-24 | 265 | 93 | 24 | PS01186 |
| Domain | EGF-like_dom | HGFAC STAB2 ADAM23 LAMA2 LAMA5 LAMB1 SVEP1 JAG2 CRELD1 CNTNAP5 FBN2 FCGBP MEGF6 MEGF8 DLL3 UMOD ADAM33 EGFL7 TNXB NOTCH3 NOTCH4 CRB2 PEAR1 | 4.37e-23 | 249 | 93 | 23 | IPR000742 |
| Domain | EGF-like_CS | HGFAC LAMB4 STAB2 ADAM23 LAMA2 LAMA5 LAMB1 SVEP1 JAG2 CRELD1 FBN2 MEGF6 MEGF8 DLL3 UMOD ADAM33 EGFL7 TNXB NOTCH3 NOTCH4 CRB2 PEAR1 | 3.23e-21 | 261 | 93 | 22 | IPR013032 |
| Domain | EGF_3 | HGFAC STAB2 ADAM23 SSPOP SVEP1 JAG2 CRELD1 CNTNAP5 FBN2 MEGF6 MEGF8 DLL3 UMOD ADAM33 EGFL7 TNXB NOTCH3 NOTCH4 CRB2 PEAR1 | 2.07e-19 | 235 | 93 | 20 | PS50026 |
| Domain | Growth_fac_rcpt_ | STAB2 LAMA5 LAMB1 HTRA3 SVEP1 JAG2 CRELD1 FBN2 MEGF6 MEGF8 DLL3 UMOD EGFL7 TNXB NOTCH3 NOTCH4 | 5.62e-17 | 156 | 93 | 16 | IPR009030 |
| Domain | EGF_CA | STAB2 SVEP1 JAG2 CRELD1 FBN2 MEGF6 MEGF8 DLL3 UMOD EGFL7 NOTCH3 NOTCH4 CRB2 | 3.43e-14 | 122 | 93 | 13 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | STAB2 SVEP1 JAG2 CRELD1 FBN2 MEGF6 MEGF8 DLL3 UMOD EGFL7 NOTCH3 NOTCH4 CRB2 | 4.25e-14 | 124 | 93 | 13 | IPR001881 |
| Domain | Laminin_EGF | 1.83e-13 | 38 | 93 | 9 | IPR002049 | |
| Domain | EGF_extracell | 3.50e-13 | 60 | 93 | 10 | IPR013111 | |
| Domain | EGF_2 | 3.50e-13 | 60 | 93 | 10 | PF07974 | |
| Domain | hEGF | 7.96e-13 | 28 | 93 | 8 | PF12661 | |
| Domain | EGF_Ca-bd_CS | SVEP1 JAG2 CRELD1 FBN2 MEGF6 MEGF8 UMOD EGFL7 NOTCH3 NOTCH4 CRB2 | 1.78e-12 | 97 | 93 | 11 | IPR018097 |
| Domain | EGF_CA | SVEP1 JAG2 CRELD1 FBN2 MEGF6 MEGF8 UMOD EGFL7 NOTCH3 NOTCH4 CRB2 | 2.24e-12 | 99 | 93 | 11 | PS01187 |
| Domain | ASX_HYDROXYL | SVEP1 JAG2 CRELD1 FBN2 MEGF6 MEGF8 UMOD EGFL7 NOTCH3 NOTCH4 CRB2 | 2.50e-12 | 100 | 93 | 11 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | SVEP1 JAG2 CRELD1 FBN2 MEGF6 MEGF8 UMOD EGFL7 NOTCH3 NOTCH4 CRB2 | 4.79e-12 | 106 | 93 | 11 | IPR000152 |
| Domain | Laminin_EGF | 5.86e-12 | 35 | 93 | 8 | PF00053 | |
| Domain | EGF_Lam | 5.86e-12 | 35 | 93 | 8 | SM00180 | |
| Domain | EGF_CA | 1.48e-11 | 86 | 93 | 10 | PF07645 | |
| Domain | EGF | HGFAC STAB2 SVEP1 JAG2 MEGF6 DLL3 UMOD TNXB NOTCH3 NOTCH4 CRB2 | 3.23e-11 | 126 | 93 | 11 | PF00008 |
| Domain | EGF_LAM_2 | 6.98e-09 | 30 | 93 | 6 | PS50027 | |
| Domain | EGF_LAM_1 | 6.98e-09 | 30 | 93 | 6 | PS01248 | |
| Domain | Laminin_N | 1.00e-06 | 16 | 93 | 4 | IPR008211 | |
| Domain | LAMININ_NTER | 1.00e-06 | 16 | 93 | 4 | PS51117 | |
| Domain | Laminin_N | 1.00e-06 | 16 | 93 | 4 | PF00055 | |
| Domain | LamNT | 1.00e-06 | 16 | 93 | 4 | SM00136 | |
| Domain | VWC | 1.21e-06 | 38 | 93 | 5 | SM00214 | |
| Domain | EMI | 1.30e-06 | 17 | 93 | 4 | PS51041 | |
| Domain | VWF_dom | 2.02e-06 | 42 | 93 | 5 | IPR001007 | |
| Domain | VWC_out | 2.11e-06 | 19 | 93 | 4 | SM00215 | |
| Domain | - | 1.92e-05 | 11 | 93 | 3 | 2.40.155.10 | |
| Domain | GFP-like | 1.92e-05 | 11 | 93 | 3 | IPR023413 | |
| Domain | TNFR/NGFR_Cys_rich_reg | 2.11e-05 | 33 | 93 | 4 | IPR001368 | |
| Domain | EGF_3 | 2.55e-05 | 12 | 93 | 3 | PF12947 | |
| Domain | TIL | 2.55e-05 | 12 | 93 | 3 | PF01826 | |
| Domain | EGF_dom | 2.55e-05 | 12 | 93 | 3 | IPR024731 | |
| Domain | C8 | 2.55e-05 | 12 | 93 | 3 | PF08742 | |
| Domain | VWFC_1 | 3.00e-05 | 36 | 93 | 4 | PS01208 | |
| Domain | Unchr_dom_Cys-rich | 3.30e-05 | 13 | 93 | 3 | IPR014853 | |
| Domain | C8 | 3.30e-05 | 13 | 93 | 3 | SM00832 | |
| Domain | VWFC_2 | 3.74e-05 | 38 | 93 | 4 | PS50184 | |
| Domain | LAM_G_DOMAIN | 3.74e-05 | 38 | 93 | 4 | PS50025 | |
| Domain | TIL_dom | 4.18e-05 | 14 | 93 | 3 | IPR002919 | |
| Domain | Laminin_G_2 | 4.59e-05 | 40 | 93 | 4 | PF02210 | |
| Domain | VWD | 6.39e-05 | 16 | 93 | 3 | SM00216 | |
| Domain | EMI_domain | 6.39e-05 | 16 | 93 | 3 | IPR011489 | |
| Domain | VWF_type-D | 6.39e-05 | 16 | 93 | 3 | IPR001846 | |
| Domain | VWFD | 6.39e-05 | 16 | 93 | 3 | PS51233 | |
| Domain | VWD | 6.39e-05 | 16 | 93 | 3 | PF00094 | |
| Domain | LamG | 6.71e-05 | 44 | 93 | 4 | SM00282 | |
| Domain | LAMININ_IVB | 7.33e-05 | 3 | 93 | 2 | PS51116 | |
| Domain | Laminin_IV_B | 7.33e-05 | 3 | 93 | 2 | IPR013015 | |
| Domain | CUB | 1.03e-04 | 49 | 93 | 4 | PF00431 | |
| Domain | Galactose-bd-like | 1.06e-04 | 94 | 93 | 5 | IPR008979 | |
| Domain | CUB | 1.11e-04 | 50 | 93 | 4 | SM00042 | |
| Domain | - | 1.12e-04 | 95 | 93 | 5 | 2.60.120.200 | |
| Domain | - | 1.30e-04 | 52 | 93 | 4 | 2.60.120.290 | |
| Domain | Sushi | 1.30e-04 | 52 | 93 | 4 | PF00084 | |
| Domain | CUB | 1.40e-04 | 53 | 93 | 4 | PS01180 | |
| Domain | Notch | 1.46e-04 | 4 | 93 | 2 | IPR008297 | |
| Domain | NODP | 1.46e-04 | 4 | 93 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 1.46e-04 | 4 | 93 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 1.46e-04 | 4 | 93 | 2 | IPR010660 | |
| Domain | NOD | 1.46e-04 | 4 | 93 | 2 | PF06816 | |
| Domain | NOD | 1.46e-04 | 4 | 93 | 2 | SM01338 | |
| Domain | NODP | 1.46e-04 | 4 | 93 | 2 | SM01339 | |
| Domain | CCP | 1.51e-04 | 54 | 93 | 4 | SM00032 | |
| Domain | SUSHI | 1.74e-04 | 56 | 93 | 4 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.86e-04 | 57 | 93 | 4 | IPR000436 | |
| Domain | CUB_dom | 1.86e-04 | 57 | 93 | 4 | IPR000859 | |
| Domain | Laminin_G | 1.99e-04 | 58 | 93 | 4 | IPR001791 | |
| Domain | DSL | 2.43e-04 | 5 | 93 | 2 | IPR001774 | |
| Domain | Laminin_aI | 2.43e-04 | 5 | 93 | 2 | IPR009254 | |
| Domain | Laminin_I | 2.43e-04 | 5 | 93 | 2 | PF06008 | |
| Domain | Laminin_II | 2.43e-04 | 5 | 93 | 2 | PF06009 | |
| Domain | DSL | 2.43e-04 | 5 | 93 | 2 | PS51051 | |
| Domain | Notch_ligand_N | 2.43e-04 | 5 | 93 | 2 | IPR011651 | |
| Domain | Laminin_domII | 2.43e-04 | 5 | 93 | 2 | IPR010307 | |
| Domain | LNR | 2.43e-04 | 5 | 93 | 2 | PS50258 | |
| Domain | MNNL | 2.43e-04 | 5 | 93 | 2 | PF07657 | |
| Domain | TNFR_NGFR_1 | 3.98e-04 | 29 | 93 | 3 | PS00652 | |
| Domain | TNFR_NGFR_2 | 3.98e-04 | 29 | 93 | 3 | PS50050 | |
| Domain | Notch_dom | 5.07e-04 | 7 | 93 | 2 | IPR000800 | |
| Domain | Notch | 5.07e-04 | 7 | 93 | 2 | PF00066 | |
| Domain | NL | 5.07e-04 | 7 | 93 | 2 | SM00004 | |
| Domain | LAMININ_IVA | 6.74e-04 | 8 | 93 | 2 | PS51115 | |
| Domain | Laminin_B | 6.74e-04 | 8 | 93 | 2 | PF00052 | |
| Domain | LamB | 6.74e-04 | 8 | 93 | 2 | SM00281 | |
| Domain | Laminin_IV | 6.74e-04 | 8 | 93 | 2 | IPR000034 | |
| Domain | ConA-like_dom | 7.92e-04 | 219 | 93 | 6 | IPR013320 | |
| Domain | - | 1.85e-03 | 13 | 93 | 2 | 2.10.10.10 | |
| Domain | Ankyrin_rpt | 1.98e-03 | 262 | 93 | 6 | IPR002110 | |
| Domain | FN_type2_col-bd | 2.15e-03 | 14 | 93 | 2 | IPR000562 | |
| Domain | FN2_2 | 2.15e-03 | 14 | 93 | 2 | PS51092 | |
| Domain | fn2 | 2.15e-03 | 14 | 93 | 2 | PF00040 | |
| Domain | FN2_1 | 2.15e-03 | 14 | 93 | 2 | PS00023 | |
| Domain | FN2 | 2.15e-03 | 14 | 93 | 2 | SM00059 | |
| Domain | WAP | 2.81e-03 | 16 | 93 | 2 | SM00217 | |
| Domain | WAP | 2.81e-03 | 16 | 93 | 2 | PF00095 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.45e-08 | 76 | 61 | 7 | M27219 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 2.20e-07 | 13 | 61 | 4 | M47423 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.11e-06 | 79 | 61 | 6 | M27643 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.60e-06 | 84 | 61 | 6 | M7098 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 5.17e-06 | 27 | 61 | 4 | M39545 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 5.37e-06 | 59 | 61 | 5 | M27218 | |
| Pathway | PID_NOTCH_PATHWAY | 5.37e-06 | 59 | 61 | 5 | M17 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 7.99e-06 | 30 | 61 | 4 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 7.99e-06 | 30 | 61 | 4 | M27216 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 9.37e-06 | 66 | 61 | 5 | M18 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.24e-05 | 11 | 61 | 3 | M158 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.85e-05 | 41 | 61 | 4 | M27778 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.05e-05 | 140 | 61 | 6 | M587 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 4.14e-05 | 45 | 61 | 4 | M39571 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 4.15e-05 | 16 | 61 | 3 | M47424 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.24e-05 | 300 | 61 | 8 | M610 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 4.52e-05 | 46 | 61 | 4 | M198 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 4.52e-05 | 46 | 61 | 4 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 4.92e-05 | 47 | 61 | 4 | M7946 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 5.80e-05 | 96 | 61 | 5 | M39834 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 6.68e-05 | 161 | 61 | 6 | M39770 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 8.34e-05 | 20 | 61 | 3 | MM15061 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.38e-04 | 61 | 61 | 4 | M39540 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 1.83e-04 | 5 | 61 | 2 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 1.83e-04 | 5 | 61 | 2 | MM14733 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.98e-04 | 67 | 61 | 4 | MM15345 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.10e-04 | 68 | 61 | 4 | M27303 | |
| Pathway | KEGG_FOCAL_ADHESION | 2.14e-04 | 199 | 61 | 6 | M7253 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 2.73e-04 | 6 | 61 | 2 | M27068 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 2.88e-04 | 30 | 61 | 3 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 2.88e-04 | 30 | 61 | 3 | MM15812 | |
| Pathway | WP_CANCER_PATHWAYS | 3.07e-04 | 507 | 61 | 9 | M48302 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 3.81e-04 | 7 | 61 | 2 | MM14734 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 3.83e-04 | 33 | 61 | 3 | M39503 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 4.73e-04 | 84 | 61 | 4 | M3228 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 5.84e-04 | 38 | 61 | 3 | MM14969 | |
| Pathway | WP_PI3KAKT_SIGNALING | 6.25e-04 | 339 | 61 | 7 | M39736 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 6.31e-04 | 39 | 61 | 3 | MM14604 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 6.50e-04 | 9 | 61 | 2 | M47866 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 7.31e-04 | 41 | 61 | 3 | MM15538 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 7.85e-04 | 42 | 61 | 3 | M7169 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 8.48e-04 | 258 | 61 | 6 | MM14572 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 9.00e-04 | 44 | 61 | 3 | M27812 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 9.88e-04 | 11 | 61 | 2 | M47865 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.03e-03 | 46 | 61 | 3 | M239 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.09e-03 | 47 | 61 | 3 | MM14925 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.18e-03 | 12 | 61 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.18e-03 | 12 | 61 | 2 | M47533 | |
| Pathway | WP_FOCAL_ADHESION | 1.27e-03 | 187 | 61 | 5 | MM15913 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.31e-03 | 50 | 61 | 3 | MM14796 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.39e-03 | 13 | 61 | 2 | M47534 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 1.69e-03 | 118 | 61 | 4 | M39852 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.87e-03 | 15 | 61 | 2 | MM14922 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.91e-03 | 57 | 61 | 3 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.98e-03 | 532 | 61 | 8 | M27870 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.01e-03 | 58 | 61 | 3 | M2049 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.32e-03 | 61 | 61 | 3 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.32e-03 | 61 | 61 | 3 | MM14637 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 2.40e-03 | 17 | 61 | 2 | M39389 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.55e-03 | 63 | 61 | 3 | M11187 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.66e-03 | 64 | 61 | 3 | M26953 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 2.70e-03 | 18 | 61 | 2 | M614 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 2.91e-03 | 66 | 61 | 3 | MM15925 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 3.00e-03 | 19 | 61 | 2 | MM15594 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 3.00e-03 | 19 | 61 | 2 | MM15512 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 3.03e-03 | 67 | 61 | 3 | M26999 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 3.39e-03 | 143 | 61 | 4 | M27275 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 3.72e-03 | 72 | 61 | 3 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 3.87e-03 | 73 | 61 | 3 | MM15906 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 4.02e-03 | 74 | 61 | 3 | M160 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 4.33e-03 | 76 | 61 | 3 | MM14573 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.33e-03 | 76 | 61 | 3 | MM14867 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 4.40e-03 | 23 | 61 | 2 | MM14954 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 4.41e-03 | 154 | 61 | 4 | M39739 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 4.78e-03 | 24 | 61 | 2 | M11190 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 5.18e-03 | 25 | 61 | 2 | M27879 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 5.36e-03 | 82 | 61 | 3 | MM15922 | |
| Pathway | REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS | 5.60e-03 | 26 | 61 | 2 | MM15270 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 5.92e-03 | 85 | 61 | 3 | M16441 | |
| Pathway | REACTOME_TRP_CHANNELS | 6.48e-03 | 28 | 61 | 2 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 6.48e-03 | 28 | 61 | 2 | M27241 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 6.48e-03 | 28 | 61 | 2 | M6177 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 6.93e-03 | 90 | 61 | 3 | M631 | |
| Pathway | REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION | 6.94e-03 | 29 | 61 | 2 | M29808 | |
| Pathway | REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS | 6.94e-03 | 29 | 61 | 2 | M27555 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | ALX3 COL3A1 COL4A3 COL9A2 ADAM23 TRPC6 LAMA2 LAMB1 KRT73 DLL3 KRT38 KRT37 NOBOX | 7.35e-03 | 1432 | 61 | 13 | M509 |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 7.41e-03 | 30 | 61 | 2 | MM15517 | |
| Pubmed | COL3A1 COL4A3 COL9A2 LAMA2 LAMA5 LAMB1 SSPOP CRELD1 FBN2 MEGF6 EGFL7 TNXB | 8.85e-14 | 175 | 97 | 12 | 28071719 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.64e-10 | 135 | 97 | 9 | 28675934 | |
| Pubmed | 5.00e-10 | 153 | 97 | 9 | 25037231 | ||
| Pubmed | 1.27e-09 | 18 | 97 | 5 | 11311202 | ||
| Pubmed | 2.99e-09 | 21 | 97 | 5 | 28656980 | ||
| Pubmed | 7.09e-09 | 9 | 97 | 4 | 11118901 | ||
| Pubmed | 7.09e-09 | 9 | 97 | 4 | 16245338 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 9.55e-09 | 26 | 97 | 5 | 34189436 | |
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 1.18e-08 | 10 | 97 | 4 | 23665443 | |
| Pubmed | Notch signaling in stomach epithelial stem cell homeostasis. | 1.71e-08 | 29 | 97 | 5 | 21402740 | |
| Pubmed | 1.85e-08 | 11 | 97 | 4 | 10878608 | ||
| Pubmed | 2.10e-08 | 3 | 97 | 3 | 12906867 | ||
| Pubmed | 2.77e-08 | 12 | 97 | 4 | 15465494 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 3.99e-08 | 13 | 97 | 4 | 11578869 | |
| Pubmed | 5.57e-08 | 14 | 97 | 4 | 14757642 | ||
| Pubmed | 7.58e-08 | 15 | 97 | 4 | 12971992 | ||
| Pubmed | 7.58e-08 | 15 | 97 | 4 | 10625553 | ||
| Pubmed | 7.58e-08 | 15 | 97 | 4 | 9264260 | ||
| Pubmed | 8.40e-08 | 4 | 97 | 3 | 22691042 | ||
| Pubmed | Laminin-1 reexpression in Alport mouse glomerular basement membranes. | 8.40e-08 | 4 | 97 | 3 | 12631063 | |
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 1.01e-07 | 16 | 97 | 4 | 12617809 | |
| Pubmed | 1.05e-07 | 41 | 97 | 5 | 22675208 | ||
| Pubmed | 1.32e-07 | 17 | 97 | 4 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 1.32e-07 | 17 | 97 | 4 | 15821257 | |
| Pubmed | 1.58e-07 | 86 | 97 | 6 | 35103284 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 1.69e-07 | 18 | 97 | 4 | 39040056 | |
| Pubmed | 1.69e-07 | 18 | 97 | 4 | 15689374 | ||
| Pubmed | 2.09e-07 | 5 | 97 | 3 | 21602525 | ||
| Pubmed | 2.37e-07 | 48 | 97 | 5 | 35247391 | ||
| Pubmed | 2.92e-07 | 50 | 97 | 5 | 23658023 | ||
| Pubmed | 4.18e-07 | 6 | 97 | 3 | 19503073 | ||
| Pubmed | 4.83e-07 | 23 | 97 | 4 | 14701881 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | LAMA5 BCL11A MDFI JAG2 PRR16 CRELD1 MEGF6 MEGF8 BEND7 EGFL7 NOTCH3 | 4.88e-07 | 560 | 97 | 11 | 21653829 |
| Pubmed | 6.53e-07 | 257 | 97 | 8 | 16335952 | ||
| Pubmed | 7.30e-07 | 7 | 97 | 3 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 7.30e-07 | 7 | 97 | 3 | 12846471 | |
| Pubmed | 7.30e-07 | 7 | 97 | 3 | 14557481 | ||
| Pubmed | Abscence of laminin alpha1 chain in the skeletal muscle of dystrophic dy/dy mice. | 7.30e-07 | 7 | 97 | 3 | 9390664 | |
| Pubmed | 8.11e-07 | 26 | 97 | 4 | 24742657 | ||
| Pubmed | 1.02e-06 | 64 | 97 | 5 | 22261194 | ||
| Pubmed | 1.17e-06 | 8 | 97 | 3 | 8872465 | ||
| Pubmed | 1.17e-06 | 8 | 97 | 3 | 9858718 | ||
| Pubmed | 1.17e-06 | 8 | 97 | 3 | 32439764 | ||
| Pubmed | Notch signaling regulates ovarian follicle formation and coordinates follicular growth. | 1.47e-06 | 30 | 97 | 4 | 24552588 | |
| Pubmed | 1.75e-06 | 9 | 97 | 3 | 10880400 | ||
| Pubmed | Notch signaling is essential for vascular morphogenesis in mice. | 1.75e-06 | 9 | 97 | 3 | 10837027 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRPM4 RASA3 AKNA LAMA5 MDFI ZBTB42 JAG2 IGF2R DNAJC14 RPAP1 MEGF6 MEGF8 PRRT4 ELL | 2.37e-06 | 1105 | 97 | 14 | 35748872 |
| Pubmed | 2.47e-06 | 34 | 97 | 4 | 21311046 | ||
| Pubmed | 2.49e-06 | 10 | 97 | 3 | 9034910 | ||
| Pubmed | Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro. | 2.49e-06 | 10 | 97 | 3 | 18590826 | |
| Pubmed | 2.49e-06 | 10 | 97 | 3 | 11784026 | ||
| Pubmed | Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. | 2.79e-06 | 35 | 97 | 4 | 21252157 | |
| Pubmed | Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development. | 3.41e-06 | 11 | 97 | 3 | 16607638 | |
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 3.41e-06 | 11 | 97 | 3 | 21524702 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 3.41e-06 | 11 | 97 | 3 | 23472759 | |
| Pubmed | 3.41e-06 | 11 | 97 | 3 | 12866128 | ||
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 3.50e-06 | 37 | 97 | 4 | 34323105 | |
| Pubmed | 4.54e-06 | 12 | 97 | 3 | 26794322 | ||
| Pubmed | 4.54e-06 | 12 | 97 | 3 | 9396756 | ||
| Pubmed | 4.81e-06 | 40 | 97 | 4 | 27068110 | ||
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 5.89e-06 | 13 | 97 | 3 | 9833687 | |
| Pubmed | 5.89e-06 | 13 | 97 | 3 | 12682087 | ||
| Pubmed | 5.89e-06 | 13 | 97 | 3 | 36350252 | ||
| Pubmed | The notch pathway positively regulates programmed cell death during erythroid differentiation. | 7.08e-06 | 44 | 97 | 4 | 17476283 | |
| Pubmed | Defining brain wiring patterns and mechanisms through gene trapping in mice. | 7.49e-06 | 14 | 97 | 3 | 11242070 | |
| Pubmed | 7.49e-06 | 14 | 97 | 3 | 28192800 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 16226104 | ||
| Pubmed | Transcriptomic data showing differentially expressed genes between Notch3 and Notch4 deleted mice. | 7.70e-06 | 2 | 97 | 2 | 33665264 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 30482841 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 24810798 | ||
| Pubmed | Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. | 7.70e-06 | 2 | 97 | 2 | 17696940 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 22113416 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 25658374 | ||
| Pubmed | Association study between the TNXB locus and schizophrenia in a Japanese population. | 7.70e-06 | 2 | 97 | 2 | 17192952 | |
| Pubmed | A genetic association study of CSMD1 and CSMD2 with cognitive function. | 7.70e-06 | 2 | 97 | 2 | 27890662 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 31922915 | ||
| Pubmed | The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. | 7.70e-06 | 2 | 97 | 2 | 21439553 | |
| Pubmed | A joint study of whole exome sequencing and structural MRI analysis in major depressive disorder. | 7.70e-06 | 2 | 97 | 2 | 30722798 | |
| Pubmed | Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients. | 7.70e-06 | 2 | 97 | 2 | 24408017 | |
| Pubmed | A genetic determinant that specifically regulates the frequency of hematopoietic stem cells. | 7.70e-06 | 2 | 97 | 2 | 11777956 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 8.00e-06 | 97 | 97 | 5 | 27559042 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | LAMA5 KRT73 FCGBP IGF2R ARSA IGFALS MEGF8 PTPRJ UMOD TNXB KRT38 KRT37 CRB2 | 8.79e-06 | 1070 | 97 | 13 | 23533145 |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 9.34e-06 | 15 | 97 | 3 | 15895400 | |
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 9.34e-06 | 15 | 97 | 3 | 12921739 | |
| Pubmed | COUP-TFI controls Notch regulation of hair cell and support cell differentiation. | 9.34e-06 | 15 | 97 | 3 | 16914494 | |
| Pubmed | 1.15e-05 | 16 | 97 | 3 | 17601529 | ||
| Pubmed | 1.15e-05 | 16 | 97 | 3 | 10842072 | ||
| Pubmed | 1.15e-05 | 16 | 97 | 3 | 17273555 | ||
| Pubmed | Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. | 1.15e-05 | 16 | 97 | 3 | 11739954 | |
| Pubmed | 1.39e-05 | 17 | 97 | 3 | 39315665 | ||
| Pubmed | Beta1-integrins are critical for cerebellar granule cell precursor proliferation. | 1.39e-05 | 17 | 97 | 3 | 15056720 | |
| Pubmed | 1.66e-05 | 18 | 97 | 3 | 18093989 | ||
| Pubmed | 1.66e-05 | 18 | 97 | 3 | 14730302 | ||
| Pubmed | 1.97e-05 | 19 | 97 | 3 | 16518823 | ||
| Pubmed | 2.07e-05 | 118 | 97 | 5 | 21078624 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 25845235 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 31882770 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 10225960 | ||
| Pubmed | Notch receptor expression in human brain arteriovenous malformations. | 2.31e-05 | 3 | 97 | 2 | 25846406 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 28705113 | ||
| Interaction | MFAP5 interactions | 1.50e-07 | 52 | 94 | 6 | int:MFAP5 | |
| Interaction | FBXO2 interactions | ADAM23 LAMA5 LAMB1 JAG2 FBN2 IGF2R MEGF8 PTPRJ ADAM33 NOTCH3 TCTN2 | 3.36e-06 | 411 | 94 | 11 | int:FBXO2 |
| Interaction | HOXA1 interactions | 6.32e-06 | 356 | 94 | 10 | int:HOXA1 | |
| Interaction | MFAP2 interactions | 2.10e-05 | 12 | 94 | 3 | int:MFAP2 | |
| Interaction | IGFL3 interactions | 2.64e-05 | 75 | 94 | 5 | int:IGFL3 | |
| Interaction | ST14 interactions | 5.24e-05 | 207 | 94 | 7 | int:ST14 | |
| GeneFamily | Laminin subunits | 7.37e-08 | 12 | 65 | 4 | 626 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 5.21e-05 | 57 | 65 | 4 | 1179 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 1.52e-04 | 29 | 65 | 3 | 782 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 3.35e-04 | 92 | 65 | 4 | 521 | |
| GeneFamily | Collagens | 6.03e-04 | 46 | 65 | 3 | 490 | |
| GeneFamily | WAP four-disulfide core domain containing|Fibronectin type III domain containing | 1.88e-03 | 18 | 65 | 2 | 361 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 4.22e-03 | 27 | 65 | 2 | 47 | |
| GeneFamily | Keratins, type I | 4.53e-03 | 28 | 65 | 2 | 608 | |
| GeneFamily | Transient receptor potential cation channels | 4.53e-03 | 28 | 65 | 2 | 249 | |
| Coexpression | NABA_MATRISOME | COL3A1 COL4A3 HGFAC LAMB4 INHBE COL9A2 ADAM23 LAMA2 LAMA5 LAMB1 HTRA3 SSPOP SVEP1 CRELD1 FBN2 IGFALS MEGF6 MEGF8 WFIKKN2 BRINP2 ADAM33 EGFL7 MUC5AC TNXB | 3.73e-13 | 1026 | 98 | 24 | M5889 |
| Coexpression | NABA_MATRISOME | COL3A1 COL4A3 HGFAC INHBE COL9A2 ADAM23 LAMA2 LAMA5 LAMB1 HTRA3 SSPOP SVEP1 CRELD1 FBN2 IGFALS MEGF6 MEGF8 WFIKKN2 BRINP2 ADAM33 EGFL7 MUC5AC TNXB | 2.10e-12 | 1008 | 98 | 23 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | COL3A1 COL4A3 LAMB4 COL9A2 LAMA2 LAMA5 LAMB1 SSPOP SVEP1 CRELD1 FBN2 IGFALS TNXB | 3.41e-11 | 275 | 98 | 13 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | COL3A1 COL4A3 COL9A2 LAMA2 LAMA5 LAMB1 SSPOP SVEP1 CRELD1 FBN2 IGFALS TNXB | 4.14e-10 | 270 | 98 | 12 | MM17057 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.44e-09 | 196 | 98 | 10 | M3008 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.32e-08 | 191 | 98 | 9 | MM17059 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.23e-07 | 16 | 98 | 4 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.23e-07 | 16 | 98 | 4 | M2207 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 3.91e-07 | 40 | 98 | 5 | M5887 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | ALX3 COL4A3 STAB2 LAMA2 LAMB1 JAG2 CD1E IGFALS MEGF6 MEGF8 KCND3 DLEC1 TNXB NOTCH3 TCTN2 | 1.40e-06 | 909 | 98 | 15 | M41018 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 1.54e-06 | 23 | 98 | 4 | M48001 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 3.46e-05 | 163 | 98 | 6 | M12112 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | HGFAC INHBE ADAM23 HTRA3 MEGF6 MEGF8 WFIKKN2 BRINP2 ADAM33 EGFL7 MUC5AC | 9.92e-05 | 738 | 98 | 11 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | HGFAC INHBE ADAM23 HTRA3 MEGF6 MEGF8 WFIKKN2 BRINP2 ADAM33 EGFL7 MUC5AC | 1.16e-04 | 751 | 98 | 11 | M5885 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 1.17e-04 | 505 | 98 | 9 | M39167 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 1.45e-04 | 303 | 98 | 7 | M39040 | |
| Coexpression | PEREZ_TP53_TARGETS | LAMB4 ADAM23 MYT1 MFSD9 ZBTB42 GASK1B JAG2 EDAR MEGF6 PTPRJ BEND7 WFDC5 MUC5AC PEAR1 | 1.49e-04 | 1201 | 98 | 14 | M4391 |
| CoexpressionAtlas | skin | LAMB4 CARMIL3 LAMA5 BCL11A KRT73 JAG2 CD1E MEGF6 PRSS53 WFDC5 KRT37 | 6.13e-06 | 456 | 95 | 11 | skin |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | ALX3 COL3A1 HGFAC COL9A2 MAP1A MYT1 SSPOP GASK1B SVEP1 PRR16 PHOX2A FBN2 ADAM33 DNAH10OS PRRT4 CRB2 | 2.62e-05 | 1094 | 95 | 16 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | COL3A1 MAP1A RASA3 ADAM23 TRPC6 LAMA2 LAMB1 GASK1B SVEP1 LHCGR FBN2 IGF2R KCND3 | 4.18e-05 | 777 | 95 | 13 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-10 | 186 | 98 | 9 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 5.06e-10 | 195 | 98 | 9 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.54e-10 | 197 | 98 | 9 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.96e-09 | 169 | 98 | 8 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-09 | 187 | 98 | 8 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-09 | 187 | 98 | 8 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-09 | 187 | 98 | 8 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-09 | 190 | 98 | 8 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 9.92e-09 | 190 | 98 | 8 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.03e-08 | 191 | 98 | 8 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-08 | 192 | 98 | 8 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-08 | 192 | 98 | 8 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.08e-08 | 192 | 98 | 8 | 09cb5b89a164ac7444774ccc8c90323c8ea2026b | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-08 | 192 | 98 | 8 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.12e-08 | 193 | 98 | 8 | dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.12e-08 | 193 | 98 | 8 | 2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-08 | 196 | 98 | 8 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-08 | 196 | 98 | 8 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.37e-08 | 198 | 98 | 8 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-08 | 200 | 98 | 8 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-08 | 200 | 98 | 8 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-08 | 200 | 98 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-08 | 200 | 98 | 8 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-08 | 200 | 98 | 8 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-08 | 200 | 98 | 8 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.84e-08 | 157 | 98 | 7 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 6.37e-08 | 159 | 98 | 7 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | -Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.13e-07 | 173 | 98 | 7 | 88be9182fbb1bc83531cd41e59ea57c112a21d54 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-07 | 176 | 98 | 7 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-07 | 176 | 98 | 7 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.49e-07 | 180 | 98 | 7 | 64956a85c404a2ea7e4eaf6f95ebcc52c198b7cc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-07 | 184 | 98 | 7 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-07 | 185 | 98 | 7 | 8433a337625ff8398520e223ef92bf9bb0beb14c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-07 | 185 | 98 | 7 | 049d793d043d5d434f143025de49dd210d18756c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-07 | 185 | 98 | 7 | 63200c42565eea596f9b00728e70e544b8d50a7f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.93e-07 | 187 | 98 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.00e-07 | 188 | 98 | 7 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-07 | 189 | 98 | 7 | ca3a04c202afc32aa11d17154066ef7dc6d01405 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-07 | 191 | 98 | 7 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.22e-07 | 191 | 98 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-07 | 192 | 98 | 7 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-07 | 192 | 98 | 7 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-07 | 192 | 98 | 7 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-07 | 192 | 98 | 7 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.30e-07 | 192 | 98 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.30e-07 | 192 | 98 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-07 | 192 | 98 | 7 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-07 | 192 | 98 | 7 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-07 | 192 | 98 | 7 | 49281626ecad0456fdbded2378b7028d7b589686 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.38e-07 | 193 | 98 | 7 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 2.38e-07 | 193 | 98 | 7 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-07 | 194 | 98 | 7 | 8f19e553f18c313c2a2ff9453884b9484b255d71 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 2.47e-07 | 194 | 98 | 7 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-07 | 194 | 98 | 7 | 67fbb81b7d20cb63be27b2a2beea5b5689f8e08c | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-07 | 195 | 98 | 7 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-07 | 195 | 98 | 7 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.56e-07 | 195 | 98 | 7 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.56e-07 | 195 | 98 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-07 | 195 | 98 | 7 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-07 | 195 | 98 | 7 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-07 | 195 | 98 | 7 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-07 | 195 | 98 | 7 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.74e-07 | 197 | 98 | 7 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.83e-07 | 198 | 98 | 7 | 12cd9f0bbad8dce5199ebfed1c4a8080710ca055 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.83e-07 | 198 | 98 | 7 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.83e-07 | 198 | 98 | 7 | aae663c6da70b6e716edeed50cc7d3962d78e697 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.93e-07 | 199 | 98 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.93e-07 | 199 | 98 | 7 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.93e-07 | 199 | 98 | 7 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.93e-07 | 199 | 98 | 7 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.93e-07 | 199 | 98 | 7 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.93e-07 | 199 | 98 | 7 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.93e-07 | 199 | 98 | 7 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-07 | 200 | 98 | 7 | 933b5b400e48a511ba0a056be1d33d3610b5f10d | |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.03e-07 | 200 | 98 | 7 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-07 | 200 | 98 | 7 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-07 | 200 | 98 | 7 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-07 | 200 | 98 | 7 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-07 | 200 | 98 | 7 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.03e-07 | 200 | 98 | 7 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.03e-07 | 200 | 98 | 7 | 69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-07 | 200 | 98 | 7 | 6e3d1ae0ef84d3075afa40129a41169996462672 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.03e-07 | 200 | 98 | 7 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-07 | 200 | 98 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-07 | 200 | 98 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-07 | 200 | 98 | 7 | 6316c288022719b9e6c4332c5cb9041e1188d0e8 | |
| ToppCell | Biopsy_IPF-Mesenchymal|Biopsy_IPF / Sample group, Lineage and Cell type | 3.03e-07 | 200 | 98 | 7 | bb605b373caf3f873dc1b87d712704568e0d6040 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-07 | 200 | 98 | 7 | 74ad0ae592252060ee294d7483327d765a6ba1dd | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-07 | 200 | 98 | 7 | 3e0041c04e42a47257517dae8707a6454570c256 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-07 | 200 | 98 | 7 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-07 | 200 | 98 | 7 | 7ba292c30d915e66ebc8026fa76492cedf64700e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-07 | 200 | 98 | 7 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.03e-07 | 200 | 98 | 7 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-07 | 200 | 98 | 7 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-07 | 200 | 98 | 7 | 5a87bb8eb1c6bd2fbc357e1528e15ba1c0051438 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.03e-07 | 200 | 98 | 7 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_C|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.06e-06 | 151 | 98 | 6 | 3f2abaa42876ce7a71d934ff16abe0cab0991a05 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 155 | 98 | 6 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.37e-06 | 158 | 98 | 6 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-3|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.53e-06 | 161 | 98 | 6 | 52239a887799362256ecd7e740b716b88ed59a62 | |
| Computational | Adhesion molecules. | 8.80e-06 | 141 | 57 | 7 | MODULE_122 | |
| Drug | 1,2-dimethylhydrazine | 7.77e-08 | 86 | 96 | 7 | CID000001322 | |
| Drug | AC1L1G72 | 9.57e-08 | 11 | 96 | 4 | CID000003553 | |
| Drug | YIGSR | 1.04e-06 | 79 | 96 | 6 | CID000123977 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.39e-06 | 83 | 96 | 6 | CID011968896 | |
| Drug | Melatonin [73-31-4]; Up 200; 17.2uM; PC3; HT_HG-U133A | 1.75e-06 | 195 | 96 | 8 | 6293_UP | |
| Drug | kalinin | 3.53e-06 | 55 | 96 | 5 | CID000032518 | |
| Drug | LG 5 | 5.45e-06 | 60 | 96 | 5 | CID011840957 | |
| Drug | AC1L1B58 | 6.50e-06 | 29 | 96 | 4 | CID000001288 | |
| Drug | AC1L1C2F | 7.22e-06 | 110 | 96 | 6 | CID000001711 | |
| Drug | Rgd Peptide | 7.85e-06 | 239 | 96 | 8 | CID000104802 | |
| Drug | hyaluronan | 1.57e-05 | 263 | 96 | 8 | CID000024759 | |
| Drug | 2-amino-5-methylpyridine | 1.86e-05 | 77 | 96 | 5 | CID000015348 | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 1.90e-05 | 195 | 96 | 7 | 4148_UP | |
| Drug | Calcort | 1.96e-05 | 38 | 96 | 4 | CID000026709 | |
| Drug | Dimethadione [695-53-4]; Up 200; 31uM; PC3; HT_HG-U133A | 1.96e-05 | 196 | 96 | 7 | 4607_UP | |
| Drug | Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.96e-05 | 196 | 96 | 7 | 2798_UP | |
| Drug | Josamycin [16846-24-5]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 1.96e-05 | 196 | 96 | 7 | 5692_UP | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Up 200; 13.2uM; PC3; HT_HG-U133A | 2.03e-05 | 197 | 96 | 7 | 4489_UP | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; PC3; HT_HG-U133A | 2.03e-05 | 197 | 96 | 7 | 3744_UP | |
| Drug | Evoxine [522-11-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | 2.03e-05 | 197 | 96 | 7 | 3681_UP | |
| Drug | DMSe | 2.05e-05 | 132 | 96 | 6 | CID000020796 | |
| Drug | Oxaprozin [21256-18-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 2.10e-05 | 198 | 96 | 7 | 4530_UP | |
| Drug | lead stearate | 2.85e-05 | 84 | 96 | 5 | CID000061258 | |
| Drug | NSC 714187 | 3.01e-05 | 85 | 96 | 5 | CID005288693 | |
| Drug | dermatan sulfate | 4.11e-05 | 220 | 96 | 7 | CID000032756 | |
| Drug | pyridinoline | 6.27e-05 | 99 | 96 | 5 | CID000105068 | |
| Drug | ALT-711 | 9.14e-05 | 21 | 96 | 3 | CID000216304 | |
| Drug | CC270 | 1.13e-04 | 59 | 96 | 4 | CID006918852 | |
| Drug | Simvastatin [79902-63-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.69e-04 | 193 | 96 | 6 | 3340_UP | |
| Drug | AG-013608 [351320-38-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.69e-04 | 193 | 96 | 6 | 5904_UP | |
| Drug | Novobiocin sodium salt [1476-53-5]; Up 200; 6.4uM; PC3; HT_HG-U133A | 1.69e-04 | 193 | 96 | 6 | 4569_UP | |
| Drug | Azacytidine-5 [320-67-2]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 1.69e-04 | 193 | 96 | 6 | 3348_UP | |
| Drug | Dropropizine (R,S) [17692-31-8]; Up 200; 17uM; MCF7; HT_HG-U133A | 1.74e-04 | 194 | 96 | 6 | 5531_UP | |
| Drug | Dioxybenzone [131-53-3]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 1.74e-04 | 194 | 96 | 6 | 5699_UP | |
| Drug | Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.74e-04 | 194 | 96 | 6 | 4492_DN | |
| Drug | Moxalactam disodium salt [64953-12-4]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.74e-04 | 194 | 96 | 6 | 5609_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.74e-04 | 194 | 96 | 6 | 2672_DN | |
| Drug | Tropicamide [1508-75-4]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.74e-04 | 194 | 96 | 6 | 4744_UP | |
| Drug | Parathion | ALX3 COL4A3 ADAM23 LAMA2 CCNO GRIN2C KRT73 PHOX2A FCGBP BEND7 HCRTR1 NOTCH4 | 1.75e-04 | 822 | 96 | 12 | ctd:D010278 |
| Drug | Dichlorphenamide [120-97-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.79e-04 | 195 | 96 | 6 | 3366_UP | |
| Drug | Bambuterol hydrochloride [81732-46-9]; Up 200; 10uM; PC3; HT_HG-U133A | 1.79e-04 | 195 | 96 | 6 | 5885_UP | |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; HL60; HT_HG-U133A | 1.79e-04 | 195 | 96 | 6 | 3078_UP | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 1.79e-04 | 195 | 96 | 6 | 7539_DN | |
| Drug | Acacetin [480-44-4]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.79e-04 | 195 | 96 | 6 | 3942_UP | |
| Drug | Benperidol [2062-84-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.79e-04 | 195 | 96 | 6 | 4781_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A | 1.79e-04 | 195 | 96 | 6 | 5582_UP | |
| Drug | Isosorbide dinitrate [87-33-2]; Up 200; 17uM; PC3; HT_HG-U133A | 1.84e-04 | 196 | 96 | 6 | 3720_UP | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.84e-04 | 196 | 96 | 6 | 6060_UP | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; PC3; HT_HG-U133A | 1.84e-04 | 196 | 96 | 6 | 4461_UP | |
| Drug | Methyldopa (L,-) [555-30-6]; Up 200; 19uM; MCF7; HT_HG-U133A | 1.89e-04 | 197 | 96 | 6 | 5637_UP | |
| Drug | CGX 0596987; Down 200; 20uM; MCF7; HT_HG-U133A | 1.89e-04 | 197 | 96 | 6 | 6412_DN | |
| Drug | Gliclazide [21187-98-4]; Up 200; 12.4uM; PC3; HT_HG-U133A | 1.89e-04 | 197 | 96 | 6 | 5089_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 1.89e-04 | 197 | 96 | 6 | 5633_UP | |
| Drug | Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.89e-04 | 197 | 96 | 6 | 3339_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.89e-04 | 197 | 96 | 6 | 4730_UP | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; MCF7; HT_HG-U133A | 1.89e-04 | 197 | 96 | 6 | 3382_UP | |
| Drug | Azathioprine [446-86-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 1.89e-04 | 197 | 96 | 6 | 5262_UP | |
| Drug | Trimipramine maleate salt [521-78-8]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 3342_UP | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 1830_DN | |
| Drug | Oxybenzone [131-57-7]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 5410_UP | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 4374_UP | |
| Drug | Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 7473_UP | |
| Drug | Ketoprofen [22071-15-4]; Up 200; 15.8uM; PC3; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 4286_UP | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 1uM; PC3; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 4292_UP | |
| Drug | Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 1466_UP | |
| Drug | Foliosidine [2520-38-9]; Up 200; 13uM; MCF7; HT_HG-U133A | 2.00e-04 | 199 | 96 | 6 | 3636_UP | |
| Drug | Bemegride [64-65-3]; Up 200; 25.8uM; PC3; HT_HG-U133A | 2.00e-04 | 199 | 96 | 6 | 6668_UP | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 2.00e-04 | 199 | 96 | 6 | 3353_UP | |
| Drug | tolbutamide; Down 200; 100uM; MCF7; HG-U133A | 2.00e-04 | 199 | 96 | 6 | 142_DN | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Up 200; 8uM; PC3; HT_HG-U133A | 2.00e-04 | 199 | 96 | 6 | 4592_UP | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; MCF7; HT_HG-U133A | 2.00e-04 | 199 | 96 | 6 | 4423_UP | |
| Drug | Monobenzone [103-16-2]; Up 200; 20uM; PC3; HT_HG-U133A | 2.00e-04 | 199 | 96 | 6 | 6713_UP | |
| Drug | Fonofos | ALX3 COL4A3 ADAM23 LAMA2 CCNO GRIN2C KRT73 PHOX2A FCGBP BEND7 HCRTR1 | 2.09e-04 | 714 | 96 | 11 | ctd:D004397 |
| Drug | terbufos | ALX3 COL4A3 ADAM23 LAMA2 CCNO GRIN2C KRT73 PHOX2A FCGBP BEND7 HCRTR1 | 2.36e-04 | 724 | 96 | 11 | ctd:C012568 |
| Drug | dysprosium | 2.72e-04 | 74 | 96 | 4 | CID000023912 | |
| Disease | Renal glomerular disease | 9.26e-07 | 23 | 97 | 4 | C0268731 | |
| Disease | Glomerulopathy Assessment | 9.26e-07 | 23 | 97 | 4 | C4521256 | |
| Disease | endoplasmic reticulum resident protein 29 measurement | 1.87e-05 | 16 | 97 | 3 | EFO_0020346 | |
| Disease | Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 measurement | 6.39e-05 | 4 | 97 | 2 | EFO_0803113 | |
| Disease | Carcinoma, Pancreatic Ductal | 6.63e-05 | 24 | 97 | 3 | C0887833 | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (is_implicated_in) | 1.06e-04 | 5 | 97 | 2 | DOID:0110274 (is_implicated_in) | |
| Disease | response to silica exposure, pneumoconiosis | 1.06e-04 | 5 | 97 | 2 | EFO_0005853, MONDO_0015926 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 1.31e-04 | 30 | 97 | 3 | C1868672 | |
| Disease | Schizophrenia | COL3A1 AHI1-DT LAMA2 BCL11A GRIN2C CSMD2 JAG2 CSMD1 TNXB HCRTR1 NOTCH4 | 1.55e-04 | 883 | 97 | 11 | C0036341 |
| Disease | X-11423--O-sulfo-L-tyrosine measurement | 1.59e-04 | 6 | 97 | 2 | EFO_0021231 | |
| Disease | hypertensive nephropathy | 1.59e-04 | 6 | 97 | 2 | C0848548 | |
| Disease | platelet component distribution width | 1.92e-04 | 755 | 97 | 10 | EFO_0007984 | |
| Disease | Malignant neoplasm of breast | INHBE NOA1 LAMA2 MFSD9 BCL11A JAG2 LHCGR BEND7 ADAM33 DLEC1 NOTCH3 NOTCH4 | 2.10e-04 | 1074 | 97 | 12 | C0006142 |
| Disease | Liver carcinoma | 2.73e-04 | 507 | 97 | 8 | C2239176 | |
| Disease | longevity | 3.58e-04 | 284 | 97 | 6 | EFO_0004300 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 3.79e-04 | 9 | 97 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | infection | 3.79e-04 | 9 | 97 | 2 | EFO_0000544 | |
| Disease | interleukin-36 alpha measurement | 3.79e-04 | 9 | 97 | 2 | EFO_0021851 | |
| Disease | Endomyocardial Fibrosis | 3.79e-04 | 9 | 97 | 2 | C0553980 | |
| Disease | Oral ulcer | 4.37e-04 | 107 | 97 | 4 | HP_0000155 | |
| Disease | Inherited focal segmental glomerulosclerosis | 4.73e-04 | 10 | 97 | 2 | cv:CN327126 | |
| Disease | ubiquitin-conjugating enzyme E2 G2 measurement | 4.73e-04 | 10 | 97 | 2 | EFO_0022035 | |
| Disease | Focal segmental glomerulosclerosis | 4.73e-04 | 10 | 97 | 2 | cv:C0017668 | |
| Disease | endometrial carcinoma | 5.37e-04 | 113 | 97 | 4 | EFO_1001512 | |
| Disease | Hereditary Nephrotic Syndromes, Autosomal Dominant | 5.77e-04 | 11 | 97 | 2 | cv:CN043612 | |
| Disease | pulse pressure measurement | HGFAC MYT1 LAMA5 PCDHA3 SSPOP SVEP1 PRR16 FBN2 MEGF8 DLEC1 IQCJ-SCHIP1 ELL NOTCH3 | 6.32e-04 | 1392 | 97 | 13 | EFO_0005763 |
| Disease | FEV/FEC ratio | BCL11A ZBTB42 CRELD1 FCGBP RPAP1 MEGF6 ADAM33 DLEC1 CSMD1 TNXB HCRTR1 CRB2 | 6.99e-04 | 1228 | 97 | 12 | EFO_0004713 |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 7.16e-04 | 53 | 97 | 3 | C4707243 | |
| Disease | Familial idiopathic steroid-resistant nephrotic syndrome | 8.15e-04 | 13 | 97 | 2 | cv:C4273714 | |
| Disease | response to lithium ion | 8.41e-04 | 56 | 97 | 3 | GO_0010226 | |
| Disease | tea consumption measurement | 8.82e-04 | 129 | 97 | 4 | EFO_0010091 | |
| Disease | inositol measurement | 9.49e-04 | 14 | 97 | 2 | EFO_0010504 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.09e-03 | 15 | 97 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Schizoaffective disorder-bipolar type | 1.25e-03 | 16 | 97 | 2 | EFO_0009965 | |
| Disease | systemic lupus erythematosus | AHI1-DT ZNF689 MYT1 FBN2 JAZF1 IQCJ-SCHIP1 EGFL7 TNXB NOTCH4 | 1.28e-03 | 799 | 97 | 9 | MONDO_0007915 |
| Disease | alpha-L-iduronidase measurement | 1.41e-03 | 17 | 97 | 2 | EFO_0020139 | |
| Disease | interstitial lung disease | 1.42e-03 | 67 | 97 | 3 | EFO_0004244 | |
| Disease | fibrinogen measurement, coronary artery disease | 1.70e-03 | 154 | 97 | 4 | EFO_0001645, EFO_0004623 | |
| Disease | tonsillectomy risk measurement | 1.70e-03 | 260 | 97 | 5 | EFO_0007924 | |
| Disease | X-11470 measurement | 1.76e-03 | 19 | 97 | 2 | EFO_0021241 | |
| Disease | Multiple Epiphyseal Dysplasia | 1.96e-03 | 20 | 97 | 2 | C0026760 | |
| Disease | squamous cell lung carcinoma | 2.18e-03 | 165 | 97 | 4 | EFO_0000708 | |
| Disease | triacylglycerol 58:9 measurement | 2.37e-03 | 22 | 97 | 2 | EFO_0010443 | |
| Disease | alcoholic liver disease | 2.53e-03 | 82 | 97 | 3 | EFO_0008573 | |
| Disease | sensory peripheral neuropathy, remission | 2.59e-03 | 23 | 97 | 2 | EFO_0009785, MONDO_0002321 | |
| Disease | Brugada Syndrome (disorder) | 2.82e-03 | 24 | 97 | 2 | C1142166 | |
| Disease | feeling nervous measurement | 2.99e-03 | 87 | 97 | 3 | EFO_0009597 | |
| Disease | complement C4b measurement | 3.05e-03 | 25 | 97 | 2 | EFO_0008092 | |
| Disease | testosterone measurement | HGFAC KIF18A MAP1A AKNA MFSD9 CSMD3 ZBTB42 LHCGR FBN2 PTPRJ JAZF1 | 3.12e-03 | 1275 | 97 | 11 | EFO_0004908 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PTCLPVACTGPGLAG | 66 | Q6ZRM9 | |
| SGLPGACGAAICQPP | 96 | Q9UHF1 | |
| PGAPADTPGLNGTCS | 481 | P55199 | |
| PPLAGCSLAGASCGP | 11 | O75077 | |
| QPDPPTCIAACGGNL | 1441 | Q96PZ7 | |
| PECGVISCGNPGTPS | 2886 | Q7Z408 | |
| PPVCIAPCGGNLTGS | 1581 | Q7Z407 | |
| GEVPQCLPKFCGDPG | 3281 | Q7Z407 | |
| CLPKFCGDPGIPAQG | 3286 | Q7Z407 | |
| LNPCPLPGDSGICDL | 46 | P22674 | |
| DGPKGEPGLLCTQCP | 466 | Q01955 | |
| DGPSNLQGSPGPCLA | 116 | O95076 | |
| CPPSLCGGAAQTGDP | 41 | P0CZ25 | |
| QLVGCSLQGGCPGPE | 361 | O60443 | |
| GTPGEAEGPACPAAC | 31 | P35858 | |
| GGACLSNAPDPGLPV | 401 | Q9BZ11 | |
| EEGPCGACPGALRPQ | 151 | P0C7V0 | |
| ATTGCLVPGPGPCDG | 266 | Q9NYJ7 | |
| APGCSPCTGGLPANI | 706 | Q14644 | |
| NPVPCGSGRGPCHLA | 231 | O60393 | |
| SCLPCPGGTERPCGG | 151 | Q96HD1 | |
| PSACNCQGTPGIPEG | 126 | Q6Y2X3 | |
| SASGPLCGFNPGPCE | 661 | Q6ZVH7 | |
| GQILCAGGTPSPIPD | 31 | Q12913 | |
| LRCSAPPTEGDCGPG | 721 | Q9Y5H8 | |
| PCGTVPGSKELPCGE | 206 | Q9UK17 | |
| CVPDGALRCPGPTAG | 36 | P22888 | |
| LLSPEQPVCPAGGSG | 2406 | P78559 | |
| LGSVCPSLCPPGGIH | 91 | Q86Y46 | |
| GVAQEVSPCGPPSLG | 431 | Q8NBP5 | |
| GTPAPILGCRGAPVC | 1046 | Q5IJ48 | |
| FGGKNCSVPREPCPG | 566 | Q9Y219 | |
| LPNPCVNGGTCVGSG | 756 | Q9Y219 | |
| LGPVQPIPCCSSSGG | 641 | Q8NI77 | |
| ACPLPGTCHIPGNIG | 76 | O76014 | |
| ACPLPGTCHIPGNIG | 76 | O76015 | |
| TGLCQECPPCGPGEE | 41 | Q9UNE0 | |
| NGGEEKPFACPVPGC | 166 | Q86VZ6 | |
| VGIPSGLGAECPSQP | 211 | Q9H165 | |
| LSDPPGCPGQGQDLS | 866 | Q8ND23 | |
| CSGQCPPHLAGSPGI | 276 | P58166 | |
| GVCSCPSGLQPPNCL | 161 | Q5VY43 | |
| GTICSLPCPEGFHGP | 256 | Q5VY43 | |
| PPCLDGSPCANGGRC | 41 | Q9UM47 | |
| GPAPCGPHGICTNLA | 816 | Q9UM47 | |
| CRPSPGPGGGLTFTC | 1261 | Q9UM47 | |
| RCGSGGPGSCPVPQE | 1406 | Q7Z7M0 | |
| NPLGTIPGGNPCDSE | 461 | P07942 | |
| GGRTPGPTLGTCVPC | 1406 | P24043 | |
| SCIGGQAPAPVCAAP | 791 | P98088 | |
| TPCDGGCDQGLVPIP | 166 | P15289 | |
| PHTGRCNCPPGLSGE | 2126 | O15230 | |
| GGPAALDPCASGPCL | 156 | Q04756 | |
| CLPGLGPCGSLKAPS | 376 | O43613 | |
| GGAPGAVLRCGPSPC | 251 | Q6UWH4 | |
| QDPSLGCGLPLNCTP | 166 | Q9NVP2 | |
| SCGPSPGPGRLQLVC | 216 | P15812 | |
| ASEGEPCGGPLDSPC | 56 | P83110 | |
| PCGGPLDSPCGESLE | 61 | P83110 | |
| GVGVPGGTCRPAPCV | 76 | P09565 | |
| SYGCPLSCGDLPVPG | 1146 | Q9Y6R7 | |
| GPVGLPGFCEPAACL | 656 | Q14055 | |
| CPLCGQVGSPPEADG | 1271 | Q7Z591 | |
| GNPLGCTPLLPNDSG | 91 | Q99750 | |
| GGSPSNPLLEPCGCV | 666 | Q8NA82 | |
| CGDPGNVPCVPLPCG | 1376 | A4D0S4 | |
| IALPPTGACGGPCTV | 406 | Q8N7W2 | |
| GPPGICESCPTGPQN | 136 | P02461 | |
| PGGFQCLCPPGFVLS | 2076 | P35556 | |
| CPDTPEGGCLLWSPG | 1326 | Q9Y238 | |
| DPALPPSGVNCSGCG | 131 | Q8NC60 | |
| GGSPPGVQQCECGLD | 711 | Q8WYK1 | |
| PPGVSGTNCEDGCPK | 586 | O75095 | |
| DPVTGTCLCPPGRAG | 1271 | O75095 | |
| GTEPCPPEAAACLLG | 1416 | P11717 | |
| GGPGGAARCPLCQEP | 46 | Q96LD4 | |
| CAGQVGPCRSGTPDP | 231 | Q2YD98 | |
| PAPLCPGVGLRCASG | 2231 | A2VEC9 | |
| QEGGPCPRLCLTQGP | 2901 | A2VEC9 | |
| EAEFCSLRPCPGPGG | 3031 | A2VEC9 | |
| SPGSVCQPGSVGCQP | 3551 | A2VEC9 | |
| GLCLQPPDGGTCVPE | 201 | P0DPB3 | |
| GGPNKIPNGDICCIP | 161 | Q569H4 | |
| GGLCLQPPDGGTCVP | 276 | B3KU38 | |
| EGSPGGISSCIPCPD | 331 | Q4LDE5 | |
| DPCPVGASCLDLPGA | 596 | Q99466 | |
| CLSGYGGPDCLTPPA | 1116 | Q99466 | |
| SCQGPIPCALGEGPA | 451 | Q9C0B6 | |
| LGGGLLCCTCPPPQV | 176 | O95484 | |
| QGSGCEGPAVAPCPG | 51 | Q9NZR4 | |
| VQGPCQGDSGGPVLC | 216 | Q2L4Q9 | |
| SGGCPPDDGPCLLSV | 31 | Q8TCV5 | |
| SPGSCGPGLDCVPEG | 151 | P07911 | |
| CIPCQPGEPGQLVGR | 436 | Q6P1M0 | |
| GPPCPALGSSNCALG | 46 | O14813 | |
| RINLPPSTGCGCPPG | 76 | P22105 | |
| GLTPALCGPCLAGLP | 131 | Q6ZSV7 | |
| GLSPTQPCPEGSGDC | 226 | P28908 | |
| QPECGPGSCSVGELP | 316 | C9JH25 | |
| GPDCIECPGGAGSPC | 106 | Q8WWQ8 | |
| APPSLVSLGCSGGCP | 866 | Q9BWH6 | |
| CKGDSGGPLVCTPEP | 246 | Q6UWB4 | |
| ELGPGGPLCICPLCS | 286 | B2RXF5 | |
| DPGQGTLCRPCPPGT | 41 | Q969Z4 | |
| IPRQTSGGPICPDCG | 141 | Q96CS4 | |
| SELGEDGCPQAPLPC | 36 | Q9Y210 | |
| CCGPRDAPLAGSEPG | 71 | A0A286YF58 | |
| QPLGPCPCNLTAGAC | 166 | Q96GX1 | |
| PLGVPRQSGRPGCCG | 746 | Q8TD43 | |
| GGSCDPLAPAGVPCA | 6 | Q15061 | |
| GPLAACSLPALQGPC | 381 | Q8TEU8 | |
| CEPGCPPAEQSQLGL | 396 | Q01538 | |
| LPAGCTGPACARPDG | 1096 | Q14957 |